Bloomfield C D, Lindquist L L, Arthur D, McKenna R W, LeBien T W, Nesbit M E, Peterson B A
Cancer Res. 1981 Nov;41(11 Pt 2):4838-43.
Chromosome abnormalities in acute lymphoblastic leukemia (ALL) and their possible clinical significance are briefly reviewed based upon the literature and 60 cases studied at the University of Minnesota. Almost all cases of ALL appear to demonstrate clonal abnormalities; the major abnormal clone is usually hyperdiploid or pseudodiploid. Among cases of non-T, non-B ALL, at least four translocations appear to be present with an increased frequency: t(9;22); t(4;11); t(11;14); and t(1;3). Patients with these translocations appear to have unique clinical and laboratory findings. Although the presence of abnormal clones does not seem to influence remission duration, the nature of the abnormality does. Patients whose leukemias demonstrate predominantly a pseudodiploid abnormal clone or a translocation have significantly shorter first remissions. Most importantly, among patients with non-T, non-B ALL, the presence or absence of translocations may separate poor responders from good responders.
基于文献以及明尼苏达大学研究的60例病例,对急性淋巴细胞白血病(ALL)中的染色体异常及其可能的临床意义进行简要综述。几乎所有ALL病例似乎都表现出克隆异常;主要的异常克隆通常是超二倍体或假二倍体。在非T、非B ALL病例中,至少有四种易位出现频率增加:t(9;22);t(4;11);t(11;14);以及t(1;3)。有这些易位的患者似乎有独特的临床和实验室表现。虽然异常克隆的存在似乎不影响缓解期,但异常的性质会有影响。白血病主要表现为假二倍体异常克隆或易位的患者首次缓解期明显较短。最重要的是,在非T、非B ALL患者中,易位的存在与否可能会区分反应差的患者和反应良好的患者。